They care for a range of patients, from patients receiving stem cell transplants and novel cellular therapies to children with relapsed cancer enrolled on clinical trials, and establish continuity of care among our cancer specialists and referring physicians. Informed by basic research done at our Sloan Kettering Institute, scientists across MSK collaborate to conduct innovative translational and clinical research that is driving a revolution in our understanding of cancer as a disease and improving the ability to prevent, diagnose, and treat it.